InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.21
(
0.00%
)
US TECH 100
19,566.00
(
-0.03%
)
Dow Jones
42,185.30
(
0.25%
)
Brent Oil
75.31
(
-2.64%
)
Bitcoin
61,846.04
(
-0.46%
)

Replies to post #142399 on Biotech Values

Replies to #142399 on Biotech Values
icon url

jq1234

05/22/12 11:29 PM

#142401 RE: BTH #142399

MetMab ph2 trial result was from last year, nothing new came out since. MetMab was well behind Tivantinib in NSCLC development. Besides, ARQL was over $8 less than two months ago. Small cap biotechs go up and down, nothing new.